$VNS therapy for medically refractory partial seizures: An update$
Código QR

Código QR

VNS therapy for medically refractory partial seizures: An update

Guardado en:

Detalles Bibliográficos
Autor principal:	James W. Wheless
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/267e21a74e9f4830a4e0420ba98cc47e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Predicting seizure response to VNS through connectomic profiling
por: George ibrahim
Publicado: (2021)

Treatment of refractory complex partial seizures: role of vigabatrin
por: Elizabeth J Waterhouse, et al.
Publicado: (2009)

Management of refractory complex partial seizures: current state of the art
por: David M Treiman
Publicado: (2010)

Dopaminergic mechanisms of VNS-induced motor system plasticity
por: Catherine Thorn
Publicado: (2021)

Parametric modulation of the heart and brain using transcutaneous auricular vagus nerve stimulation (taVNS)
por: Bashar Badran
Publicado: (2021)

Diffusional kurtosis imaging reveals taVNS facilitates microstructural changes in the developing neonatal brain
por: Hunter Moss, et al.
Publicado: (2021)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
por: Noda Y, et al.
Publicado: (2014)

Effects of VNS paired with rehabilitation for chronic upper limb recovery post stroke: cross-over response
por: Teresa Kimberley, et al.
Publicado: (2021)

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
por: Sarah Huffman, et al.
Publicado: (2021)

The effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on hypoxic-ischemic injury in newborn rats
por: Melanie Wiley, et al.
Publicado: (2021)

At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
por: Christopher Austelle, et al.
Publicado: (2021)

Predicting response to transcutaneous auricular vagus nerve stimulation (taVNS) paired with oromotor feeding in neonates: CNS metabolite biomarkers by MR spectroscopy (MRS)
por: Sally Hunt, et al.
Publicado: (2021)

Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
por: Lauren Adams, et al.
Publicado: (2021)

Retrospective Review of Clinical Effects, Tolerability and Outcomes of Deep Brain Stimulation (DBS) and Vagal Nerve Stimulation (VNS) in Patients Aged 23 and Younger
por: Deniz Yuruk, et al.
Publicado: (2021)

Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010)

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
por: Carol M Ulloa, et al.
Publicado: (2009)

Quantitative ictal electroencephalography (qEEG) comparison of Focal Electrically-Administered Seizure Therapy (FEAST) and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (UBP-RUL ECT)
por: Kevin Caulfield, et al.
Publicado: (2021)

Profile of perampanel and its potential in the treatment of partial onset seizures
por: Rheims S, et al.
Publicado: (2013)

Tiagabine: efficacy and safety in partial seizures &ndash; current status
por: J&uuml;rgen Bauer, et al.
Publicado: (2008)

Medial temporal seizures breakdown effective connectivity within the hippocampal network
por: Simone Russo, et al.
Publicado: (2021)

Vagus nerve electroneurogram-based detection of acute pentylenetetrazol induced seizures in rats
por: Lars Stumpp, et al.
Publicado: (2021)

Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
por: Jos&eacute; F. Tellez-Zenteno, et al.
Publicado: (2008)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
por: Markus Rauchenzauner, et al.
Publicado: (2010)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg JLZ, et al.
Publicado: (2011)

Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
por: Cormier J, et al.
Publicado: (2013)

Reliability of TMS-derived hand motor mapping across development in clinical cohort with refractory epilepsy or brain tumor
por: Mia Fox, et al.
Publicado: (2021)

Treatment of refractory obsessive-compulsive disorder with comorbid major depression with sequential multi-locus transcranial magnetic stimulation
por: Reza Tadayonnejad, et al.
Publicado: (2021)

The mechanisms of action of vagus nerve stimulation in difficult-to-treat depression: An update
por: Harold Sackeim
Publicado: (2021)

Long‐term continuation of anti‐seizure medications after acute stroke
por: Vineet Punia, et al.
Publicado: (2021)

Variability in TMS-EEG response can partially be described by the phase of ongoing brain oscillation
por: Mohsen Poorganji, et al.
Publicado: (2021)

The Emerging Role of Scalogram-Based Convolutional Neural Network in the Diagnosis of Epileptic Seizures
por: Evanthia Bernitsas
Publicado: (2021)

Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process
por: Anzellotti F, et al.
Publicado: (2014)

Clobazam as an adjunctive therapy in treating seizures associated with Lennox&ndash;Gastaut syndrome
por: Leahy JT, et al.
Publicado: (2011)

Real world evidence of age-independent electroconvulsive therapy efficacy: a retrospective cohort study
por: James Luccarelli, et al.
Publicado: (2021)

Vagus nerve stimulation in patients receiving maintenance therapy with electroconvulsive therapy: a series of 10 cases
por: Scott Aaronson, et al.
Publicado: (2021)

Current state of electromagnetic neuromodulation therapy
por: Mark S. George
Publicado: (2021)

Current state of ultrasound neuromodulation therapy
por: Roland Beisteiner
Publicado: (2021)

Cellular mechanisms of electromagnetic neuromodulation therapy
por: Vincenzo DiLazzaro
Publicado: (2021)

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
por: Manoj K. Doss, et al.
Publicado: (2021)

The effectiveness of non-clozapine antipsychotics combined with electroconvulsive therapy versus clozapine combined with electroconvulsive therapy for treatment-resistant schizophrenia
por: Pichai Ittasakul, et al.
Publicado: (2021)